To the safety of Influenza vaccine, the production process is based on the cell lines - Reply

被引：0
|
作者：
Fickenscher, Helmut [1 ,2 ]
机构：
[1] Univ Kiel, Inst Infekt Med, D-24105 Kiel, Germany
[2] Univ Klinikum Schleswig Holstein, D-24105 Kiel, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2009年 / 134卷 / 48期
关键词：
D O I：
10.1055/s-0029-1243033
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2472 / 2472
页数：1
相关论文
共 50 条
  • [21] Influenza vaccine for all? Reply
    Langley, JM
    Feightner, J
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (09) : 1162 - 1163
  • [22] Continuous cell lines as a production system for influenza vaccines
    Genzel, Yvonne
    Reichl, Udo
    EXPERT REVIEW OF VACCINES, 2009, 8 (12) : 1681 - 1692
  • [23] Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children - Reply
    Marczynska, M
    ACTA PAEDIATRICA, 2002, 91 (04) : 487 - 487
  • [24] Analyzing the Impact of Heterogeneity in Genetically Engineered Cell Lines for Influenza Vaccine Production Using Population Balance Modeling
    Duerr, Robert
    Dnvigneau, Stefanie
    Laske, Tanja
    Bachmann, Mandy
    Kienle, Achim
    IFAC PAPERSONLINE, 2016, 49 (26): : 225 - 230
  • [25] The growth of attenuated influenza vaccine donor strains in continuous cell lines
    Audsley, JM
    Tannock, GA
    JOURNAL OF VIROLOGICAL METHODS, 2005, 123 (02) : 187 - 193
  • [26] Suspended cell lines for inactivated virus vaccine production
    Zhang, Jiayou
    Qiu, Zhenyu
    Wang, Siya
    Liu, Zhenbin
    Qiao, Ziling
    Wang, Jiamin
    Duan, Kai
    Nian, Xuanxuan
    Ma, Zhongren
    Yang, Xiaoming
    EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 468 - 480
  • [27] Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine
    Domnich, Alexander
    Amicizia, Daniela
    Lai, Piero Luigi
    Ogliastro, Matilde
    Piedrahita-Tovar, Maria
    Orsi, Andrea
    Icardi, Giancarlo
    Panatto, Donatella
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [28] Accounting for the Entire Influenza Hemagglutinin during a Flu Vaccine Production Process
    Kroeber, T.
    Wolff, M. W.
    Lehmann, S.
    Zimmermann, A.
    Reichl, Udo
    PROCEEDINGS OF THE 21ST ANNUAL MEETING OF THE EUROPEAN SOCIETY FOR ANIMAL CELL TECHNOLOGY (ESACT), 2009, 2012, 5 : 685 - 689
  • [29] A baseline process for the production, recovery, and purification of bacterial influenza vaccine candidates
    Sanchez-Arreola, Pamela B.
    Lopez-Uriarte, Salvador
    Marichal-Gallardo, Pavel A.
    Gonzalez-Vazquez, Juan C.
    Perez-Chavarria, Roberto
    Soto-Vazquez, Pedro
    Lopez-Pacheco, Felipe
    Ramirez-Medrano, Alicia
    Rocha-Pizana, Maria R.
    Alvarez, Mario M.
    BIOTECHNOLOGY PROGRESS, 2013, 29 (04) : 896 - 908
  • [30] Monitoring cell physiology in influenza vaccine production by flow cytometry
    Schulze-Horsel, Josef
    Genzel, Yvonne
    Reichl, Udo
    CELL TECHNOLOGY FOR CELL PRODUCTS, 2007, : 531 - +
12345